Auvi-q Injection, Solution
Product Images NDC 71872-7172

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 20 technical images submitted to the FDA as part of the official labeling for Auvi-q (NDC 71872-7172). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Medical Purchasing Solutions, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

71872-7172-1 Pdp (7172)

71872-7172-1 Pdp (7172)
This is a description of Auvi-Q epinephrine Injection, USP, a 0.15mg prefilled auto-injector that is used for allergic emergencies in patients weighing 33-66 Ib. It is a single-use injection that should be refilled after use. The product contains 0.15 mg epinephrine, 1.2 mg sodium chloride, 0.2 mg sodium bisulfite, and water for injection. The product should not be refrigerated or frozen and must be protected from heat and light. If the solution becomes discolored, cloudy, or contains particles, it should be replaced. The product should be stored at room temperature between 88° to 77°F (20° to 25°C). The manufacturer of the product is Kaleo, Inc, based in Richmond, VA, and it is manufactured in Germany. The product is repackaged and distributed by Medical Purchasing Solutions in Scottsdale, AZ. Enclosed patient information leaflets and trainer instructions are provided with the product.*
FDA Label Image

Chemical Structure (Auvi Q 01)

Chemical Structure (Auvi Q 01)
FDA Label Image

Figure A (Auvi Q 02)

Figure A (Auvi Q 02)
This appears to be a description of a device outer case that includes a viewing window and a red safety guard. There is a black needle end and a base, but no further information is available to determine what type of device this may be referring to.*
FDA Label Image

Figure B (Auvi Q 03)

Figure B (Auvi Q 03)
FDA Label Image

Figure C (Auvi Q 04)

Figure C (Auvi Q 04)
FDA Label Image

Figure D (Auvi Q 05)

Figure D (Auvi Q 05)
FDA Label Image

Figure E (Auvi Q 06)

Figure E (Auvi Q 06)
FDA Label Image

Figure A1 (Auvi Q 07)

Figure A1 (Auvi Q 07)
The text is describing different parts of a product, including an outer case, LEDs, a base, and a safety guard. No further information is available.*
FDA Label Image

Figure A2 (Auvi Q 08)

Figure A2 (Auvi Q 08)
FDA Label Image

Figure A3 (Auvi Q 09)

Figure A3 (Auvi Q 09)
FDA Label Image

Figure A4 (Auvi Q 10)

Figure A4 (Auvi Q 10)
FDA Label Image

Figure A5 (Auvi Q 11)

Figure A5 (Auvi Q 11)
FDA Label Image

Figure B (Auvi Q 12)

Figure B (Auvi Q 12)
FDA Label Image

Figure C (Auvi Q 13)

Figure C (Auvi Q 13)
FDA Label Image

Figure D (Auvi Q 14)

Figure D (Auvi Q 14)
FDA Label Image

Figure E (Auvi Q 15)

Figure E (Auvi Q 15)
FDA Label Image

Figure F (Auvi Q 16)

Figure F (Auvi Q 16)
FDA Label Image

Figure G (Auvi Q 17)

Figure G (Auvi Q 17)
FDA Label Image

0.15 mg Outer Case Label (Auvi Q 22)

0.15 mg Outer Case Label (Auvi Q 22)
Auvi-Q is a single-use epinephrine injection for patients weighing between 33 lb to 66 lb during allergic emergencies. The device contains instructions for use and should be refilled with a prescription after use. It is important not to refrigerate or freeze the auto-injector, protecting it from light and storing it within permissible temperatures of 68° to 77°F (20°to 25°C), with restrictions from 59° to 86°F (15° to 30°C). In case the solution becomes discolored or cloudy, or if it contains particles, the auto-injector needs to be replaced. Auvi-Q is manufactured for kaléo, with additional information available on their website.*
FDA Label Image

0.15 mg Device Label (Auvi Q 23)

0.15 mg Device Label (Auvi Q 23)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.